Tamoxifen and the uterus.
作者信息
Neven P, De Muylder X, Van Belle Y, Campo R, Vanderick G
出版信息
BMJ. 1994 Nov 19;309(6965):1313-4. doi: 10.1136/bmj.309.6965.1313.
Abstract
摘要
相似文献
1
Tamoxifen and the uterus.他莫昔芬与子宫
BMJ. 1994 Nov 19;309(6965):1313-4. doi: 10.1136/bmj.309.6965.1313.
2
Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.
Gynecol Oncol. 1994 Feb;52(2):185-90. doi: 10.1006/gyno.1994.1029.
3
The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.他莫昔芬对绝经后乳腺癌患者子宫内膜、血脂及下丘脑 - 垂体轴的影响。
Acta Obstet Gynecol Scand. 2000 Jul;79(7):604-7.
4
Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.辅助性他莫昔芬对绝经后乳腺癌女性子宫内膜的影响：一项使用经阴道超声的前瞻性长期研究
J Clin Oncol. 2000 Oct 15;18(20):3464-70. doi: 10.1200/JCO.2000.18.20.3464.
5
Gynecologic surveillance of women on tamoxifen: first do no harm.
J Clin Oncol. 2000 Oct 15;18(20):3457-8. doi: 10.1200/JCO.2000.18.20.3457.
6
Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.接受他莫昔芬治疗的患者子宫的异常超声表现。
Am J Obstet Gynecol. 1994 Feb;170(2):447-51. doi: 10.1016/s0002-9378(94)70209-8.
7
Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.接受他莫昔芬治疗的绝经后乳腺癌患者的子宫内膜评估：一项超声、彩色多普勒血流、宫腔镜及组织学研究。
Ultrasound Obstet Gynecol. 1995 Dec;6(6):435-42. doi: 10.1046/j.1469-0705.1995.06060435.x.
8
Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.绝经后乳腺癌患者使用他莫昔芬后子宫内膜超声检查、宫腔镜检查及组织学之间的差异。
Gynecol Oncol. 1999 Apr;73(1):21-6. doi: 10.1006/gyno.1998.5316.
9
Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.他莫昔芬治疗的绝经后乳腺癌女性中类似子宫内膜肿瘤的变化：经阴道多普勒研究
Ultrasound Obstet Gynecol. 1995 Aug;6(2):116-20. doi: 10.1046/j.1469-0705.1995.06020116.x.
10
Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.
AJR Am J Roentgenol. 1993 Apr;160(4):809-12. doi: 10.2214/ajr.160.4.8456669.
引用本文的文献
1
[Not Available].[无可用内容]。
Arch Gynecol Obstet. 1995 Dec;256(Suppl 1):S122-S127. doi: 10.1007/BF02201946.
2
Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.左炔诺孕酮宫内节育系统用于避孕的获益-风险评估。
Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003.
3
Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment.对接受他莫昔芬治疗的乳腺癌患者进行经阴道超声检查以监测子宫内膜癌。
Br J Cancer. 2003 Apr 22;88(8):1175-9. doi: 10.1038/sj.bjc.6600894.
4
The demise of the D&C.刮宫术的衰落。
J R Soc Med. 1998 Feb;91(2):76-9. doi: 10.1177/014107689809100207.
5
Tamoxifen and secondary tumours. An update.他莫昔芬与继发性肿瘤。最新进展。
Drug Saf. 1997 Feb;16(2):104-17. doi: 10.2165/00002018-199716020-00003.
本文引用的文献
1
Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.
AJR Am J Roentgenol. 1993 Apr;160(4):809-12. doi: 10.2214/ajr.160.4.8456669.
2
Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen.
J Ultrasound Med. 1993 May;12(5):275-80. doi: 10.7863/jum.1993.12.5.275.
3
Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer.
Br J Obstet Gynaecol. 1993 Jun;100(6):567-70. doi: 10.1111/j.1471-0528.1993.tb15310.x.
4
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.他莫昔芬治疗的乳腺癌患者中的子宫内膜癌：来自国家外科辅助乳腺和肠道项目（NSABP）B-14的研究结果。
J Natl Cancer Inst. 1994 Apr 6;86(7):527-37. doi: 10.1093/jnci/86.7.527.
5
Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.接受他莫昔芬治疗的患者子宫的异常超声表现。
Am J Obstet Gynecol. 1994 Feb;170(2):447-51. doi: 10.1016/s0002-9378(94)70209-8.
6
Pathology of endometrium treated with tamoxifen.
J Clin Pathol. 1994 Sep;47(9):827-33. doi: 10.1136/jcp.47.9.827.
7
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial.
Lancet. 1994 May 28;343(8909):1318-21. doi: 10.1016/s0140-6736(94)92466-x.
8
Endometrial cancer during tamoxifen treatment.
Lancet. 1994 Apr 16;343(8903):978.
9
Risk of endometrial cancer after tamoxifen treatment of breast cancer.乳腺癌患者接受他莫昔芬治疗后患子宫内膜癌的风险。
Lancet. 1994 Feb 19;343(8895):448-52. doi: 10.1016/s0140-6736(94)92692-1.
10
Tamoxifen and the uterus and endometrium.
Lancet. 1989 Feb 18;1(8634):375.
Zotero 插件